91 related articles for article (PubMed ID: 1833171)
1. Complement in vitro inhibition by a low-sulfate chondroitin sulfate (matrix).
Biffoni M; Paroli E
Drugs Exp Clin Res; 1991; 17(1):35-9. PubMed ID: 1833171
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the function of activated properdin by squid chondroitin sulfate E glycosaminoglycan and murine bone marrow-derived mast cell chondroitin sulfate E proteoglycan.
Wilson JG; Fearon DT; Stevens RL; Seno N; Austen KF
J Immunol; 1984 Jun; 132(6):3058-63. PubMed ID: 6427331
[TBL] [Abstract][Full Text] [Related]
3. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
[TBL] [Abstract][Full Text] [Related]
4. Multimeric tyrosine sulfate acts as an endothelial cell protectant and prevents complement activation in xenotransplantation models.
Laumonier T; Walpen AJ; Matozan KM; Korchagina EY; Bovin NV; Haeberli A; Mohacsi PJ; Rieben R
Xenotransplantation; 2004 May; 11(3):262-8. PubMed ID: 15099206
[TBL] [Abstract][Full Text] [Related]
5. Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate.
Glauser BF; Pereira MS; Monteiro RQ; Mourão PA
Thromb Haemost; 2008 Sep; 100(3):420-8. PubMed ID: 18766257
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory drugs and the complement system. A condensation product of metacresolsulfonic acid and formaldehyde prevents instantly the complement activation in vitro.
Gancevici GG; Popescu C
Arch Roum Pathol Exp Microbiol; 1989; 48(2):157-62. PubMed ID: 2634368
[No Abstract] [Full Text] [Related]
7. Action of S 5682 on the complement system. In vitro and in vivo study.
Di Perri T; Auteri A
Int Angiol; 1988; 7(2 Suppl):11-5. PubMed ID: 3183451
[TBL] [Abstract][Full Text] [Related]
8. [Anti-inflammatory action of a hyaluronic acid-chondroitin sulfate preparation in an in vitro bladder model].
Schulz A; Vestweber AM; Dressler D
Aktuelle Urol; 2009 Mar; 40(2):109-12. PubMed ID: 19296424
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of equine complement activity by polysulfated glycosaminoglycans.
Rashmir-Raven AM; Coyne CP; Fenwick BW; Gaughan EM; Andrews GA; DeBowes RM
Am J Vet Res; 1992 Jan; 53(1):87-90. PubMed ID: 1539920
[TBL] [Abstract][Full Text] [Related]
10. Preparation and biological activity of N-sulfonated chondroitin and dermatan sulfate derivatives.
Nadkarni VD; Toida T; Van Gorp CL; Schubert RL; Weiler JM; Hansen KP; Caldwell EE; Linhardt RJ
Carbohydr Res; 1996 Aug; 290(1):87-96. PubMed ID: 8805784
[No Abstract] [Full Text] [Related]
11. Soluble glycosaminoglycans Do not potentiate RANTES antiviral activity on the infection of primary macrophages by human immunodeficiency virus type 1.
Ylisastigui L; Bakri Y; Amzazi S; Gluckman JC; Benjouad A
Virology; 2000 Dec; 278(2):412-22. PubMed ID: 11118364
[TBL] [Abstract][Full Text] [Related]
12. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
Fonseca RJ; Mourão PA
Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
[TBL] [Abstract][Full Text] [Related]
13. Action of a new non-steroid antiinflammatory drug, nimesulide, on activation of the complement system: an in vitro study.
Auteri A; Saletti M; Blardi P; Di Perri T
Int J Tissue React; 1988; 10(4):217-21. PubMed ID: 3250936
[TBL] [Abstract][Full Text] [Related]
14. Dextran sulfate acts as an endothelial cell protectant and inhibits human complement and natural killer cell-mediated cytotoxicity against porcine cells.
Laumonier T; Walpen AJ; Maurus CF; Mohacsi PJ; Matozan KM; Korchagina EY; Bovin NV; Vanhove B; Seebach JD; Rieben R
Transplantation; 2003 Sep; 76(5):838-43. PubMed ID: 14501864
[TBL] [Abstract][Full Text] [Related]
15. The effects of glycosaminoglycans on surface-mediated interactions of lymphoid cells.
Viklický V; Pokorná Z; Pĕknicová J
Folia Biol (Praha); 1975; 21(2):87-94. PubMed ID: 126179
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory activities of sulfated proteoglycans on chondroitin sulfate A-mediated cytoadherence of Plasmodium falciparum isolates from Thailand.
Chaisavaneeyakorn S; Kongtawelert P; Angkasekwinai P; McGready R; Nosten F; Chaiyaroj SC
Am J Trop Med Hyg; 2004 Feb; 70(2):149-57. PubMed ID: 14993626
[TBL] [Abstract][Full Text] [Related]
18. A small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation.
Goslings WR; Prodeus AP; Streilein JW; Carroll MC; Jager MJ; Taylor AW
Invest Ophthalmol Vis Sci; 1998 May; 39(6):989-95. PubMed ID: 9579478
[TBL] [Abstract][Full Text] [Related]
19. The effect of chondroitin-sulfate and hyaluronic acid on glycosaminoglycan and collagen synthesis and secretion by cultured arterial endothelial cells.
Bihari-Varga M; Csonka E; Gruber E; Jellinek H
Pathol Biol (Paris); 1981 Nov; 29(9):562-6. PubMed ID: 6798534
[TBL] [Abstract][Full Text] [Related]
20. Suppression of atherogenesis in hypercholesterolemic rabbits by chondroitin-6-sulfate.
Matsushima T; Nakashima Y; Sugano M; Tasaki H; Kuroiwa A; Koide O
Artery; 1987; 14(6):316-37. PubMed ID: 3118854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
